Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
MOHAMMED SHAHZAD AHMED MALIK
AddedFeb 15, 2024
UpdatedMay 1, 2026
MOHAMMED SHAHZAD AHMED MALIK

MOHAMMED SHAHZAD AHMED MALIK

Board Member, Acutus Medical

MOHAMMED SHAHZAD AHMED MALIK's Career

Acutus Medical
Acutus Medical

Carlsbad, CA, US

Board Member· Board
Moximed
Moximed

Hayward, CA, US

Board Member· Board
Pathwork Diagnostics
Pathwork Diagnostics

Redwood City, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

MOHAMMED SHAHZAD AHMED MALIK's Career

Acutus Medical
Acutus Medical
Acquired$343.2M02011Carlsbad, CA, US
Board Member· Board

Leadership at Acutus Medical

Kevin JohnsonKevin JohnsonBoard Member
Shaden MarzoukShaden MarzoukBoard Member
Randy WernethRandy WernethBoard Member
Jason GarlandJason GarlandBoard Member
Scott HuennekensScott HuennekensBoard Member
John SheridanJohn SheridanBoard Member

Similar to Acutus Medical

AtriCureAtriCureMason, OH, USPain Management, Surgical Devicesest. 2000AtriCureMason, OH, US · est. 2000

AtriCure, Inc. develops and sells surgical devices for precise lesion creation in soft tissues, serving customers globally.

Public · $26M260
AtaCor MedicalAtaCor MedicalSan Clemente, CA, USMedical Devicesest. 2014AtaCor MedicalSan Clemente, CA, US · est. 2014

AtaCor Medical Inc.: Innovating cardiac pacing solutions as a leading medical device maker.

Series B · $34M23
Atrility MedicalAtrility MedicalMadison, WI, USMedical Devicesest. 2017Atrility MedicalMadison, WI, US · est. 2017

Cardiac device manufacturer setting new standards in arrhythmia monitoring with AtriAmp.

Series A · $4M9
CoreMapCoreMapBurlington, VT, USMedical Devicesest. 2016CoreMapBurlington, VT, US · est. 2016

CoreMap: Enhancing patient outcomes with advanced diagnostic technology for electrophysiologists.

Series A · $33.8M35
Moximed
Moximed
Public$183.2M452006Hayward, CA, US
Board Member· Board

Leadership at Moximed

Brigitte SmithBrigitte SmithBoard Member
Bob MoreBob MoreBoard Member
Josh MakowerJosh MakowerBoard Member
Arthur FrankenArthur FrankenBoard Member
Anton CliffordAnton CliffordCo-Founder
Kevin SidowKevin SidowCo-Founder & CEO
Pathwork Diagnostics
Pathwork Diagnostics
Acquired$63.5M02002Redwood City, CA, US
Board Member· Board

Leadership at Pathwork Diagnostics

Ken HaasKen HaasBoard Member
Peter KlemmPeter KlemmBoard Member
Richard KlausnerRichard KlausnerFounder
Greg LahannGreg LahannBoard Member
Richard BastianiRichard BastianiBoard Member
Jim TananbaumJim TananbaumBoard Member

Similar to Pathwork Diagnostics

NanopathNanopathCambridge, MA, USDiagnostics, Womens Healthest. 2019NanopathCambridge, MA, US · est. 2019

Nanopath: A molecular diagnostics firm revolutionizing testing for women's health in a single visit.

Series A · $10.3M30
OncocyteOncocyteIrvine, CA, USCancer Diagnosticsest. 2009OncocyteIrvine, CA, US · est. 2009

Oncocyte Corporation: A US-based molecular diagnostics firm, optimizing cancer care through accelerated diagnosis and treatment.

Public · $57.2M75
CblpathCblpathOcala, FL, USLaboratory Services, Molecular Diagnosticsest. 2003CblpathOcala, FL, US · est. 2003

CBLPath, Inc.: Leading provider of specialized pathology and molecular diagnostic lab services since 1988.

Seed · $3.2M124
PrecipioPrecipioNew Haven, CT, USCancer Diagnosticsest. 2011PrecipioNew Haven, CT, US · est. 2011

Precipio: A leading cancer diagnostics lab, providing expert advice for optimal patient care.

Public · $3.3M68

MOHAMMED SHAHZAD AHMED MALIK's Similar Executives & Operators

Jay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoYun SeokYun SeokBoard Member · Kakao

People Similar to MOHAMMED SHAHZAD AHMED MALIK

Mike RossMike RossBoard Member · Deciphera PharmaceuticalsMichael MandahlMichael MandahlBoard Member · ConformiqFrankFrankBoard Member · CertainMark C JensenMark C JensenBoard Member · American ResourcesIra LamelIra LamelBoard Member · Whole Earth BrandsMark MealyMark MealyBoard Member · ARC Document Solutions